Carlin Consumer Health Acquires Zegerid OTC from Bayer
February 1, 2022
Hildred Capital, Bourne Partners Strategic Capital and The Emerson Group launched Carlin Consumer Health and acquired the Zegerid OTC brand from Bayer AG to establish a consumer health/OTC platform. The investors plan to invest in marketing, sales and product development to grow the Zegerid brand across U.S. retail channels; financial terms were not disclosed.
- Targets
- Zegerid OTC
- Sellers
- Bayer AG
- Industry
- Pharmaceuticals
- Location
- United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.